Informuta

Informuta develops RESISENSE, a diagnostic platform that uses machine learning and Next-Generation Sequencing (NGS) to analyze bacterial DNA. It uniquely predicts both current and future antibiotic resistance, allowing for more precise treatment decisions. This technology is designed to improve patient outcomes by enabling faster, more accurate diagnostics and providing prognostics for the first time.